Refining Risk Stratification Among Children With Latent Rheumatic Heart Disease

Written By RRCU Staff

Andrea Beaton, MD; Emmy Okello, PhD; Joselyn Rwebembera, MMed; Anneke Grobler, PhD; Daniel Engelman, PhD; Juliet Alepere, BA; Jonathan Carapetis, PhD; Alyssa DeWyer, MD; Peter Lwabi, MMed; Mariana Mirabel, PhD; Ana Olga Mocumbi, PhD; Miriam Nakitto, MPH; Emma Ndagire, MMed; Maria Carmo P. Nunes, PhD; Isaac Otim Omara, BNS; Rachel Sarnacki, BA; Amy Scheel, MD; Nigel Wilson, PhD; Liesl Zühlke, PhD; Ganesan Karthikeyan, MD; Craig A. Sable, MD; Andrew C. Steer, PhD.

Circulation Volume 147, Issue 24, 13 June 2023; Pages 1848-1850.

RRCU Staff
Previous

Oral anticoagulation for atrial fibrillation in rheumatic heart disease
Next

Research Opportunities for the Primary Prevention and Management of Acute Rheumatic Fever and Rheumatic Heart Disease: A National Heart, Lung, and Blood Institute Workshop Report